KindlyMD (NASDAQ:NAKA - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.34) EPS for the quarter, Zacks reports. The firm had revenue of $0.41 million during the quarter. KindlyMD had a negative return on equity of 131.09% and a negative net margin of 244.00%.
KindlyMD Stock Performance
Shares of NAKA traded up $2.07 during mid-day trading on Friday, hitting $9.57. The stock had a trading volume of 654,338 shares, compared to its average volume of 301,723. The stock has a market capitalization of $72.83 million, a P/E ratio of -11.13 and a beta of 34.35. The company's fifty day moving average price is $12.04. KindlyMD has a fifty-two week low of $0.65 and a fifty-two week high of $34.77.
About KindlyMD
(
Get Free Report)
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
See Also
Before you consider KindlyMD, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KindlyMD wasn't on the list.
While KindlyMD currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
